TREM2 and Alzheimer disease: Genome-wide association studies (GWAS) have found that innate immune-related genes such as TREM2 (Triggering Receptor Expressed on Myeloid Cells 2) are associated with the risk of sporadic AD, independent of apolipoprotein E4 status [3].